American Century Companies
ALXN

American Century Companies’s Alexion Pharmaceuticals ALXN Stock Holding History

American Century Companies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,821
Closed -$4.56M – 2390
2021
Q2 		$4.56M Sell
24,821
-823
-3% -$141K ﹤0.01% 1008
2021
Q1 		$3.92M Sell
25,644
-79,138
-76% -$12.2M ﹤0.01% 1000
2020
Q4 		$16.4M Sell
104,782
-136,593
-57% -$17.6M 0.01% 664
2020
Q3 		$27.6M Buy
241,375
+214,383
+794% +$23.1M 0.02% 468
2020
Q2 		$3.03M Buy
26,992
+22,359
+483% +$2.37M ﹤0.01% 823
2020
Q1 		$416K Sell
4,633
-307,364
-99% -$30.2M ﹤0.01% 1209
2019
Q4 		$33.7M Sell
311,997
-301,961
-49% -$32.3M 0.03% 412
2019
Q3 		$60.1M Sell
613,958
-431,069
-41% -$48.6M 0.06% 317
2019
Q2 		$137M Sell
1,045,027
-39,712
-4% -$5.12M 0.14% 206
2019
Q1 		$147M Sell
1,084,739
-276,234
-20% -$34.3M 0.15% 188
2018
Q4 		$133M Sell
1,360,973
-543,323
-29% -$64.2M 0.15% 191
2018
Q3 		$265M Buy
1,904,296
+1,183,476
+164% +$148M 0.26% 106
2018
Q2 		$89.5M Buy
720,820
+64,792
+10% +$7.57M 0.09% 268
2018
Q1 		$73.1M Sell
656,028
-191,155
-23% -$22.8M 0.07% 301
2017
Q4 		$101M Sell
847,183
-72,891
-8% -$8.88M 0.1% 262
2017
Q3 		$129M Buy
920,074
+122,703
+15% +$16.7M 0.13% 221
2017
Q2 		$97M Sell
797,371
-410,487
-34% -$47.8M 0.1% 256
2017
Q1 		$146M Sell
1,207,858
-68,469
-5% -$8.83M 0.15% 198
2016
Q4 		$156M Sell
1,276,327
-133,764
-9% -$16.4M 0.17% 180
2016
Q3 		$173M Buy
1,410,091
+132,540
+10% +$17.1M 0.19% 157
2016
Q2 		$149M Sell
1,277,551
-193,314
-13% -$27.4M 0.17% 171
2016
Q1 		$205M Sell
1,470,865
-169,181
-10% -$24.8M 0.24% 121
2015
Q4 		$313M Sell
1,640,046
-468,943
-22% -$81.9M 0.37% 69
2015
Q3 		$330M Sell
2,108,989
-139,979
-6% -$25.5M 0.4% 54
2015
Q2 		$407M Sell
2,248,968
-499,687
-18% -$86.2M 0.46% 48
2015
Q1 		$476M Sell
2,748,655
-163,691
-6% -$29.6M 0.53% 33
2014
Q4 		$539M Sell
2,912,346
-343,372
-11% -$63.6M 0.61% 26
2014
Q3 		$540M Buy
3,255,718
+489,231
+18% +$80.3M 0.63% 23
2014
Q2 		$432M Buy
2,766,487
+404,739
+17% +$63.9M 0.49% 42
2014
Q1 		$359M Buy
2,361,748
+343,489
+17% +$54.6M 0.42% 44
2013
Q4 		$269M Sell
2,018,259
-569,569
-22% -$68.4M 0.32% 82
2013
Q3 		$301M Sell
2,587,828
-634,880
-20% -$69.7M 0.38% 65
2013
Q2 		$297M Buy
+3,222,708
New +$311M 0.39% 63

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

American Century Companies's ALXN Position: Q3 2021 in Review

American Century Companies sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 24,821 shares — an estimated $4.56M sold.

American Century Companies first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $540M in Q3 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • American Century Companies reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • American Century Companies sold 24,821 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4.56M.
  • American Century Companies first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • American Century Companies's Alexion Pharmaceuticals position peaked at $540M in Q3 2014.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on American Century Companies's 13F filing for Q3 2021, filed 10 Nov 2021.